Ipr1 Gene Mediates RAW 264.7 Macrophage Cell Line Resistance to Mycobacterium bovis

Scandinavian Journal of Immunology

Volumn 74, Issue 5, 2011, Pages 438-444

  He, X N ^a   Su, F ^a   Lou, Z Z ^b   Jia, W Z ^b   Song, Y L ^c   Chang, H Y ^b   Wu, Y H ^a   Lan, J ^d   He, X Y ^a   Zhang, Y ^a  

^a NORTHWEST A F UNIVERSITY   (China)

^b Lanzhou Veterinary Research Institute   (China)

^c JILIN AGRICULTURAL SCIENCE AND TECHNOLOGY COLLEGE   (China)

^d SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; INTRACELLULAR PATHOGEN RESISTANCE PROTEIN 1; LENTIVIRUS VECTOR; MESSENGER RNA; PROTEIN; PROTEIN MCL 1; PROTEIN NOS2A; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; INFECTION RESISTANCE; MACROPHAGE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CATTLE; CELL LINE, TUMOR; CELL SURVIVAL; DISEASE MODELS, ANIMAL; GENETIC VECTORS; IMMUNITY, ACTIVE; INFECTION CONTROL; LENTIVIRUS; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MYCOBACTERIUM BOVIS; NECROSIS; TRANS-ACTIVATORS; TRANSGENES; TUBERCULOSIS, BOVINE; VIRULENCE;

EID: 80053488715     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2011.02596.x     Document Type: Article

References (34)

1. Thoen CO, Lobue PA, Enarson DA, Kaneene JB, de Kantor IN. Tuberculosis: a re-emerging disease in animals and humans. Vet Ital 2009;45:135-81.
2. Grange JM. Mycobacterium bovis infection in human beings. Tuberculosis 2001;81:71-7.
3. Thoen C, LoBue P, de Kantor I. The importance of Mycobacterium bovis as a zoonosis. Vet Microbiol 2006;25:112.
4. Acha PN, Szyfres B. eds. Salmonellosis. In: Zoonoses and Communicable Diseases Common to Man and Animals, 2nd edn. Washington: Pan American Health Organization, 1987;503:147-155.
5. Buddle BM, Pollock JM, Skinner MA, Wedlock DN. Development of vaccines to control bovine tuberculosis in cattle and relationship to vaccine development for other intracellular pathogens. Int J Parasitol 2003;33:555-66.
6. Cosivi O, Grange JM, Daborn CJ et al. Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg Infect Dis 1998;4:59-70.
7. Niemann H, Kues W, Carnwath JW. Transgenic farm animals: present and future. Rev Sci Tech 2005;24:285-98.
8. van Crevel R, Ottenhoff TH, van der Meer JW. Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev 2002;15:294-309.
9. Danelishvili L, McGarvey J, Li YJ, Bermudez LE. Mycobacterium tuberculosis infection causes different levels of apoptosis and necrosis in human macrophages and alveolar epithelial cells. Cell Microbiol 2003;5:649-60.
10. Keane J, Balcewicz-Sablinska MK, Remold HG et al. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun 1997;65:298-304.
11. Ottenhoff THM, Verreck FAW, Lichtenauer-Kaligis EGR, Hoeve MA, Sanal O, van Dissel JT. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nat Genet 2002;32:97-105.
12. Mosser DM. The many faces of macrophage activation. J Leukoc Biol 2003;73:209-12.
13. Park JS, Tamayo MH, Gonzalez-Juarrero M, Orme IM, Ordway DJ. Virulent clinical isolates of Mycobacterium tuberculosis grow rapidly and induce cellular necrosis but minimal apoptosis in murine macrophages. J Leukoc Biol 2006;79:80-6.
14. Molloy A, Laochumroonvorapong P, Kaplan G. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin. J Exp Med 1994;180:1499-509.
15. Keane J, Remold HG, Kornfeld H. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J Immunol 2000;164:2016-20.
16. Placido R, Mancino G, Amendola A et al. Apoptosis of human monocytes/macrophages in Mycobacterium tuberculosis infection. J Pathol 1997;181:31-8.
17. Kramnik I, Dietrich WF, Demant P, Bloom BR. Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 2000;97:8560-5.
18. Pan H, Yan BS, Rojas M et al. Ipr1 gene mediates innate immunity to tuberculosis. Nature 2005;434:767-72.
19. Velez DR, Hulme WF, Myers JL et al. NOS2A, TLR4, and IFNGR1 interactions influence pulmonary tuberculosis susceptibility in African-Americans. Hum Genet 2009;126:643-53.
20. Ordway D, Viveiros M, Leandro C et al. Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 2003;47:917-22.
21. Pan H, Mostoslavsky G, Eruslanov E, Kotton DN, Kranmik I. Dual-promoter lentiviral system allows inducible expression of noxious proteins in macrophages. J Immunol Methods 2008;329:31-44.
22. Raschke WC, Baird S, Ralph P, Nakoinz I. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 1978;15:261-7.
23. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178:2249-54.
24. Secko D. Science and medicine - a gene for susceptibility to tuberculosis. Can Med Assoc J 2005;172:1436.
25. Krysko DV, D'Herde K, Vandenabeele P. Clearance of apoptotic and necrotic cells and its immunological consequences. Apoptosis 2006;11:1709-26.
26. Riendeau CJ, Kornfeld H. THP-1 cell apoptosis in response to Mycobacterial infection. Infect Immun 2003;71:254-9.
27. Moller M, Hoal EG. Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis. Tuberculosis (Edinb) 2010;90:71-83.
28. Ehrt S, Schnappinger D, Bekiranov S et al. Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J Exp Med 2001;194:1123-40.
29. Mogga SJ, Mustafa T, Sviland L, Nilsen R. Increased Bcl-2 and reduced Bax expression in infected macrophages in slowly progressive primary murine Mycobacterium tuberculosis infection. Scand J Immunol 2002;56:383-91.
30. Scanga CA, Mohan VP, Tanaka K, Alland D, Flynn JL, Chan J. The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice. Infect Immun 2001;69:7711-7.
31. Gomez LM, Anaya JM, Vilchez JR et al. A polymorphism in the inducible nitric oxide synthase gene is associated with tuberculosis. Tuberculosis 2007;87:288-94.
32. Alnemri ES, Livingston DJ, Nicholson DW et al. Human ICE/CED-3 protease nomenclature. Cell 1996;87:171.
33. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993;75:241-51.
34. Sly LM, Hingley-Wilson SM, Reiner NE, McMaster WR. Survival of Mycobacterium tuberculosis in host macrophages involves resistance to apoptosis dependent upon induction of antiapoptotic Bcl-2 family member Mcl-1. J Immunol 2003;170:430-7.